🇺🇸 FDA
Patent

US 6596705

Inhibition of L-selectin and P-selection mediated binding using heparin

expired A61KA61K31/727

Quick answer

US patent 6596705 (Inhibition of L-selectin and P-selection mediated binding using heparin) held by The Regents of the University of California expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/727